|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1101 to 1200 out of 2547 for Pten

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.023s

Categories

Category: Publication
« show all
Type Details Score
Publication
29784854 | J:264280
First Author: Saito R
Year: 2018
Journal: Cancer Res
Title: Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy.
Volume: 78
Issue: 14
Pages: 3954-3968
•
•
•
•
•
Publication
39242942 | J:360605
First Author: Dong B
Year: 2024
Journal: Nat Cancer
Title: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.
Volume: 5
Issue: 9
Pages: 1427-1447
•
•
•
•
•
Publication
39303726 | J:357411
First Author: Calì B
Year: 2024
Journal: Cancer Cell
Title: Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Volume: 42
Issue: 10
Pages: 1676-1692.e11
•
•
•
•
•
Publication
37804830 | J:341960
First Author: Mossmann D
Year: 2023
Journal: Cell
Title: Arginine reprograms metabolism in liver cancer via RBM39.
Volume: 186
Issue: 23
Pages: 5068-5083.e23
•
•
•
•
•
Publication
26620760 | J:259911
First Author: Sander S
Year: 2015
Journal: Immunity
Title: PI3 Kinase and FOXO1 Transcription Factor Activity Differentially Control B Cells in the Germinal Center Light and Dark Zones.
Volume: 43
Issue: 6
Pages: 1075-86
•
•
•
•
•
Publication
25723392 | J:226290
First Author: Wang WM
Year: 2015
Journal: PLoS One
Title: Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
Volume: 10
Issue: 2
Pages: e0119723
•
•
•
•
•
Publication
29033351 | J:253959
First Author: Köhler C
Year: 2017
Journal: Cell Stem Cell
Title: Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes.
Volume: 21
Issue: 5
Pages: 679-693.e6
•
•
•
•
•
Publication
34375613 | J:309725
First Author: Jun S
Year: 2021
Journal: Cell Metab
Title: The requirement for pyruvate dehydrogenase in leukemogenesis depends on cell lineage.
Volume: 33
Issue: 9
Pages: 1777-1792.e8
•
•
•
•
•
Publication
27798955 | J:239245
First Author: Mao L
Year: 2017
Journal: Int J Cancer
Title: Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
Volume: 140
Issue: 5
Pages: 1173-1185
•
•
•
•
•
Publication
29047105 | J:248036
     
First Author: Mao L
Year: 2017
Journal: Int J Cancer
Title: γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
•
•
•
•
•
Publication
28111070 | J:239513
First Author: Spitzer MH
Year: 2017
Journal: Cell
Title: Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Volume: 168
Issue: 3
Pages: 487-502.e15
•
•
•
•
•
Publication
28747781 | J:253029
First Author: Bu LL
Year: 2017
Journal: Sci Rep
Title: Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model.
Volume: 7
Issue: 1
Pages: 6629
•
•
•
•
•
Publication
38640236 | J:348259
First Author: Niu L
Year: 2024
Journal: Sci Adv
Title: Noncovalently particle-anchored cytokines with prolonged tumor retention safely elicit potent antitumor immunity.
Volume: 10
Issue: 16
Pages: eadk7695
•
•
•
•
•
Publication
21493594 | J:170965
First Author: Ellwood-Yen K
Year: 2011
Journal: Cancer Res
Title: PDK1 attenuation fails to prevent tumor formation in PTEN-deficient transgenic mouse models.
Volume: 71
Issue: 8
Pages: 3052-65
•
•
•
•
•
Publication
29389670 | J:263614
First Author: Zordan P
Year: 2018
Journal: J Clin Invest
Title: Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt.
Volume: 128
Issue: 4
Pages: 1688-1706
•
•
•
•
•
Publication
32323921 | J:294705
First Author: Oberhuber M
Year: 2020
Journal: Mol Syst Biol
Title: STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
Volume: 16
Issue: 4
Pages: e9247
•
•
•
•
•
Publication
34547241 | J:315701
First Author: Igelmann S
Year: 2021
Journal: Mol Cell
Title: A hydride transfer complex reprograms NAD metabolism and bypasses senescence.
Volume: 81
Issue: 18
Pages: 3848-3865.e19
•
•
•
•
•
Publication
37055829 | J:334748
First Author: Alvarez-Arzola R
Year: 2023
Journal: Cell Commun Signal
Title: VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer.
Volume: 21
Issue: 1
Pages: 76
•
•
•
•
•
Publication
28807943 | J:245648
First Author: Bainor AJ
Year: 2017
Journal: Cancer Res
Title: Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.
Volume: 77
Issue: 19
Pages: 5339-5348
•
•
•
•
•
Publication
35584006 | J:326292
First Author: Davidson SM
Year: 2022
Journal: Cancer Res
Title: Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma.
Volume: 82
Issue: 13
Pages: 2403-2416
•
•
•
•
•
Publication
25099011 | J:216207
First Author: Xie Y
Year: 2014
Journal: Mol Endocrinol
Title: Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.
Volume: 28
Issue: 10
Pages: 1629-39
•
•
•
•
•
Publication
24145418 | J:202916
First Author: Yuan P
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.
Volume: 110
Issue: 45
Pages: 18226-31
•
•
•
•
•
Publication
21278735 | J:169306
First Author: Biton M
Year: 2011
Journal: Nat Immunol
Title: Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk.
Volume: 12
Issue: 3
Pages: 239-46
•
•
•
•
•
Publication
30914431 | J:276351
First Author: Shurin GV
Year: 2019
Journal: Cancer Res
Title: Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.
Volume: 79
Issue: 10
Pages: 2736-2747
•
•
•
•
•
Publication
28433543 | J:243339
First Author: Kim SH
Year: 2017
Journal: J Invest Dermatol
Title: Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma.
Volume: 137
Issue: 8
Pages: 1740-1748
•
•
•
•
•
Publication
30662519 | J:307277
First Author: Lui JW
Year: 2019
Journal: J Cancer
Title: The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
Volume: 10
Issue: 1
Pages: 1-10
•
•
•
•
•
Publication
24746818 | J:277956
First Author: Luo X
Year: 2014
Journal: Cell Rep
Title: Isolation and molecular characterization of circulating melanoma cells.
Volume: 7
Issue: 3
Pages: 645-53
•
•
•
•
•
Publication
36332622 | J:332355
First Author: Han M
Year: 2022
Journal: Cancer Cell
Title: FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer.
Volume: 40
Issue: 11
Pages: 1306-1323.e8
•
•
•
•
•
Publication
30824837 | J:285318
First Author: Long JE
Year: 2019
Journal: Cell Death Differ
Title: Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation.
Volume: 26
Issue: 11
Pages: 2416-2429
•
•
•
•
•
Publication
16288012 | J:103408
First Author: Hill R
Year: 2005
Journal: Cancer Res
Title: Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model.
Volume: 65
Issue: 22
Pages: 10243-54
•
•
•
•
•
Publication
35143421 | J:330262
 
First Author: Wu Z
Year: 2022
Journal: J Clin Invest
Title: SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells.
Volume: 132
Issue: 7
•
•
•
•
•
Publication
27341128 | J:240369
First Author: Das SK
Year: 2016
Journal: Oncotarget
Title: Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Volume: 7
Issue: 30
Pages: 46848-46861
•
•
•
•
•
Publication
26901150 | J:259144
First Author: Gonzalez-Martin A
Year: 2016
Journal: Nat Immunol
Title: The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity.
Volume: 17
Issue: 4
Pages: 433-40
•
•
•
•
•
Publication
24670665 | J:210464
First Author: Signer RA
Year: 2014
Journal: Nature
Title: Haematopoietic stem cells require a highly regulated protein synthesis rate.
Volume: 509
Issue: 7498
Pages: 49-54
•
•
•
•
•
Publication
24335650 | J:208368
First Author: White AC
Year: 2014
Journal: Nat Cell Biol
Title: Stem cell quiescence acts as a tumour suppressor in squamous tumours.
Volume: 16
Issue: 1
Pages: 99-107
•
•
•
•
•
Publication
30930118 | J:274188
First Author: Rios AC
Year: 2019
Journal: Cancer Cell
Title: Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.
Volume: 35
Issue: 4
Pages: 618-632.e6
•
•
•
•
•
Publication
37352863 | J:357456
First Author: Wang H
Year: 2023
Journal: Cancer Cell
Title: Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.
Volume: 41
Issue: 7
Pages: 1345-1362.e9
•
•
•
•
•
Publication
28387316 | J:253496
 
First Author: Zhang H
Year: 2017
Journal: Nat Commun
Title: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.
Volume: 8
Pages: 14922
•
•
•
•
•
Publication
23340180 | J:194341
First Author: Zhang L
Year: 2013
Journal: Cancer Lett
Title: MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma.
Volume: 331
Issue: 2
Pages: 230-8
•
•
•
•
•
Publication
22461511 | J:189341
First Author: Zhang Q
Year: 2012
Journal: Cancer Res
Title: Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models.
Volume: 72
Issue: 10
Pages: 2589-99
•
•
•
•
•
Publication
23845440 | J:199223
First Author: Karantanos T
Year: 2013
Journal: Cancer Cell
Title: GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer.
Volume: 24
Issue: 1
Pages: 11-3
•
•
•
•
•
Publication
20679199 | J:163589
First Author: Furic L
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.
Volume: 107
Issue: 32
Pages: 14134-9
•
•
•
•
•
Publication
24691994 | J:210809
First Author: Le Mercier I
Year: 2014
Journal: Cancer Res
Title: VISTA Regulates the Development of Protective Antitumor Immunity.
Volume: 74
Issue: 7
Pages: 1933-44
•
•
•
•
•
Publication
27052162 | J:235087
First Author: Katlinskaya YV
Year: 2016
Journal: Cell Rep
Title: Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.
Volume: 15
Issue: 1
Pages: 171-80
•
•
•
•
•
Publication
28986383 | J:249341
First Author: Brady DC
Year: 2017
Journal: Cancer Res
Title: Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors.
Volume: 77
Issue: 22
Pages: 6240-6252
•
•
•
•
•
Publication
35649375 | J:326093
First Author: Han L
Year: 2022
Journal: Cell Rep
Title: Muscle satellite cells are impaired in type 2 diabetic mice by elevated extracellular adenosine.
Volume: 39
Issue: 9
Pages: 110884
•
•
•
•
•
Publication
31433989 | J:285688
First Author: Di Mitri D
Year: 2019
Journal: Cell Rep
Title: Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer.
Volume: 28
Issue: 8
Pages: 2156-2168.e5
•
•
•
•
•
Publication
26198641 | J:224447
 
First Author: Pencik J
Year: 2015
Journal: Nat Commun
Title: STAT3 regulated ARF expression suppresses prostate cancer metastasis.
Volume: 6
Pages: 7736
•
•
•
•
•
Publication
24711431 | J:208854
First Author: McFadden DG
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.
Volume: 111
Issue: 16
Pages: E1600-9
•
•
•
•
•
Publication
35624211 | J:330339
First Author: Yeo AT
Year: 2022
Journal: Nat Immunol
Title: Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.
Volume: 23
Issue: 6
Pages: 971-984
•
•
•
•
•
Publication
29185453 | J:255776
First Author: Xie Y
Year: 2017
Journal: Sci Rep
Title: Dysregulation of YAP by ARF Stimulated with Tea-derived Carbon Nanodots.
Volume: 7
Issue: 1
Pages: 16577
•
•
•
•
•
Publication
20237562 | J:158121
First Author: Lin HK
Year: 2010
Journal: Nature
Title: Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Volume: 464
Issue: 7287
Pages: 374-9
•
•
•
•
•
Publication
27728797 | J:236719
First Author: Murray NR
Year: 2016
Journal: Cancer Cell
Title: SOX2 Determines Lineage Restriction: Modeling Lung Squamous Cell Carcinoma in the Mouse.
Volume: 30
Issue: 4
Pages: 505-507
•
•
•
•
•
Publication
27683179 | J:350188
First Author: Zhang KJ
Year: 2017
Journal: Clin Cancer Res
Title: A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon.
Volume: 23
Issue: 8
Pages: 2038-2049
•
•
•
•
•
Publication
19016531 | J:141373
First Author: Henley T
Year: 2008
Journal: Eur J Immunol
Title: B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta.
Volume: 38
Issue: 12
Pages: 3543-8
•
•
•
•
•
Publication
25056937 | J:317519
First Author: Nazarian A
Year: 2014
Journal: Mol Cell Proteomics
Title: Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Volume: 13
Issue: 11
Pages: 3082-96
•
•
•
•
•
Publication
28484008 | J:242200
First Author: Beirowski B
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells.
Volume: 114
Issue: 21
Pages: E4261-E4270
•
•
•
•
•
Publication
23136410 | J:192244
First Author: McMahon J
Year: 2012
Journal: J Neurosci
Title: Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis.
Volume: 32
Issue: 45
Pages: 15704-14
•
•
•
•
•
Publication
29846864 | J:318499
First Author: Wu CC
Year: 2018
Journal: J Mol Histol
Title: Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.
Volume: 49
Issue: 4
Pages: 389-398
•
•
•
•
•
Publication
29202479 | J:258828
First Author: Shoag J
Year: 2018
Journal: J Clin Invest
Title: SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
Volume: 128
Issue: 1
Pages: 381-386
•
•
•
•
•
Publication
36868226 | J:347460
First Author: Bancaro N
Year: 2023
Journal: Cancer Cell
Title: Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.
Volume: 41
Issue: 3
Pages: 602-619.e11
•
•
•
•
•
Publication
28273450 | J:251063
First Author: Chen CF
Year: 2017
Journal: Cell Rep
Title: ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.
Volume: 18
Issue: 10
Pages: 2331-2342
•
•
•
•
•
Publication
36368445 | J:332391
     
First Author: Dong B
Year: 2022
Journal: J Invest Dermatol
Title: FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial‒Mesenchymal Transition.
•
•
•
•
•
Publication
37270599 | J:354056
First Author: Yang J
Year: 2023
Journal: Mol Cancer
Title: CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth.
Volume: 22
Issue: 1
Pages: 92
•
•
•
•
•
Publication
31375534 | J:289994
First Author: Etzerodt A
Year: 2019
Journal: J Exp Med
Title: Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.
Volume: 216
Issue: 10
Pages: 2394-2411
•
•
•
•
•
Publication
33953176 | J:306090
First Author: Di Leo L
Year: 2021
Journal: Nat Commun
Title: Loss of Ambra1 promotes melanoma growth and invasion.
Volume: 12
Issue: 1
Pages: 2550
•
•
•
•
•
Publication
20147383 | J:157922
First Author: Xing Y
Year: 2010
Journal: Development
Title: Signaling via Alk5 controls the ontogeny of lung Clara cells.
Volume: 137
Issue: 5
Pages: 825-33
•
•
•
•
•
Publication
31366581 | J:279767
 
First Author: Liu Y
Year: 2019
Journal: Sci Transl Med
Title: The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.
Volume: 11
Issue: 503
•
•
•
•
•
Publication
26577921 | J:301636
First Author: Hsieh AC
Year: 2015
Journal: Sci Signal
Title: Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors.
Volume: 8
Issue: 403
Pages: ra116
•
•
•
•
•
Publication
21850021 | J:180641
First Author: Colombo S
Year: 2012
Journal: J Invest Dermatol
Title: Transcriptomic analysis of mouse embryonic skin cells reveals previously unreported genes expressed in melanoblasts.
Volume: 132
Issue: 1
Pages: 170-8
•
•
•
•
•
Publication
31204281 | J:282052
First Author: Hu Z
Year: 2019
Journal: Cell Metab
Title: Acylglycerol Kinase Maintains Metabolic State and Immune Responses of CD8+ T Cells.
Volume: 30
Issue: 2
Pages: 290-302.e5
•
•
•
•
•
Publication
31914399 | J:287620
First Author: Hidalgo San Jose L
Year: 2020
Journal: Cell Rep
Title: Modest Declines in Proteome Quality Impair Hematopoietic Stem Cell Self-Renewal.
Volume: 30
Issue: 1
Pages: 69-80.e6
•
•
•
•
•
Publication
28202513 | J:242087
First Author: Steinberg SM
Year: 2017
Journal: Cancer Res
Title: Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.
Volume: 77
Issue: 7
Pages: 1599-1610
•
•
•
•
•
Publication
36599297 | J:332546
First Author: Tsai CH
Year: 2023
Journal: Cell Metab
Title: Immunoediting instructs tumor metabolic reprogramming to support immune evasion.
Volume: 35
Issue: 1
Pages: 118-133.e7
•
•
•
•
•
Publication
30664764 | J:282386
First Author: Cheng WC
Year: 2019
Journal: Nat Immunol
Title: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.
Volume: 20
Issue: 2
Pages: 206-217
•
•
•
•
•
Publication
24493834 | J:208767
First Author: Trent CM
Year: 2014
Journal: J Lipid Res
Title: Lipoprotein lipase activity is required for cardiac lipid droplet production.
Volume: 55
Issue: 4
Pages: 645-58
•
•
•
•
•
Publication
24910389 | J:316436
First Author: Xie Y
Year: 2014
Journal: Mol Oncol
Title: Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.
Volume: 8
Issue: 7
Pages: 1355-64
•
•
•
•
•
Publication
25058027 | J:213943
First Author: Daikoku T
Year: 2014
Journal: Am J Pathol
Title: Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.
Volume: 184
Issue: 9
Pages: 2390-402
•
•
•
•
•
Publication
34155349 | J:308175
First Author: Liang SK
Year: 2021
Journal: Oncogene
Title: FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
Volume: 40
Issue: 30
Pages: 4847-4858
•
•
•
•
•
Publication
37516803 | J:339727
First Author: Arumi-Planas M
Year: 2023
Journal: Oncogene
Title: Microenvironmental Snail1-induced immunosuppression promotes melanoma growth.
Volume: 42
Issue: 36
Pages: 2659-2672
•
•
•
•
•
Publication
22916036 | J:188124
First Author: Tanwar PS
Year: 2012
Journal: PLoS Genet
Title: Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.
Volume: 8
Issue: 8
Pages: e1002906
•
•
•
•
•
Publication
31754005 | J:287851
First Author: Moya IM
Year: 2019
Journal: Science
Title: Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
Volume: 366
Issue: 6468
Pages: 1029-1034
•
•
•
•
•
Publication
30247156 | J:271009
First Author: Fu X
Year: 2018
Journal: J Clin Invest
Title: Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss.
Volume: 128
Issue: 11
Pages: 4938-4955
•
•
•
•
•
Publication
27728805 | J:236713
First Author: Dardenne E
Year: 2016
Journal: Cancer Cell
Title: N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
Volume: 30
Issue: 4
Pages: 563-577
•
•
•
•
•
Publication
28274958 | J:243131
First Author: Patnaik A
Year: 2017
Journal: Cancer Discov
Title: Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.
Volume: 7
Issue: 7
Pages: 750-765
•
•
•
•
•
Publication
29309058 | J:275855
First Author: Bezzi M
Year: 2018
Journal: Nat Med
Title: Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms.
Volume: 24
Issue: 2
Pages: 165-175
•
•
•
•
•
Publication
23563312 | J:201460
First Author: Hanna SC
Year: 2013
Journal: J Clin Invest
Title: HIF1α and HIF2α independently activate SRC to promote melanoma metastases.
Volume: 123
Issue: 5
Pages: 2078-93
•
•
•
•
•
Publication
33690225 | J:306045
 
First Author: Huang F
Year: 2021
Journal: J Clin Invest
Title: Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Volume: 131
Issue: 8
•
•
•
•
•
Publication
24736544 | J:212454
First Author: Ho PC
Year: 2014
Journal: Cancer Res
Title: Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.
Volume: 74
Issue: 12
Pages: 3205-17
•
•
•
•
•
Publication
33199895 | J:323597
First Author: Brunner JS
Year: 2020
Journal: Nat Metab
Title: The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages.
Volume: 2
Issue: 12
Pages: 1427-1442
•
•
•
•
•
Publication
23348745 | J:194482
First Author: Yoshioka T
Year: 2013
Journal: J Clin Invest
Title: β4 Integrin signaling induces expansion of prostate tumor progenitors.
Volume: 123
Issue: 2
Pages: 682-99
•
•
•
•
•
Publication
15967113 | J:100163
First Author: Hu X
Year: 2005
Journal: Neoplasia
Title: mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Volume: 7
Issue: 4
Pages: 356-68
•
•
•
•
•
Publication
16869764 | J:116748
 
First Author: Simin K
Year: 2005
Journal: Cold Spring Harb Symp Quant Biol
Title: Deciphering cancer complexities in genetically engineered mice.
Volume: 70
Pages: 283-90
•
•
•
•
•
Publication
22791749 | J:187754
First Author: Tanwar PS
Year: 2012
Journal: Hum Mol Genet
Title: Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis.
Volume: 21
Issue: 20
Pages: 4394-405
•
•
•
•
•
Publication
35425962 | J:324033
First Author: Yousefi M
Year: 2022
Journal: Cancer Res
Title: Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities.
Volume: 82
Issue: 8
Pages: 1589-1602
•
•
•
•
•
Publication
29055016 | J:252305
First Author: Orlacchio A
Year: 2017
Journal: Cancer Res
Title: SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.
Volume: 77
Issue: 24
Pages: 6914-6926
•
•
•
•
•
Publication
21572435 | J:172653
First Author: Vitari AC
Year: 2011
Journal: Nature
Title: COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Volume: 474
Issue: 7351
Pages: 403-6
•
•
•
•
•
Publication
23454771 | J:196375
First Author: Knight DA
Year: 2013
Journal: J Clin Invest
Title: Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Volume: 123
Issue: 3
Pages: 1371-81
•
•
•
•
•
Publication
26678340 | J:227408
First Author: Blaisdell A
Year: 2015
Journal: Cancer Cell
Title: Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells.
Volume: 28
Issue: 6
Pages: 785-799
•
•
•
•
•
Publication
37451271 | J:346107
First Author: Meiser P
Year: 2023
Journal: Cancer Cell
Title: A distinct stimulatory cDC1 subpopulation amplifies CD8(+) T cell responses in tumors for protective anti-cancer immunity.
Volume: 41
Issue: 8
Pages: 1498-1515.e10
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom